Clinica Baviera (XMAD:CBAV) Moat Score: 0/10 (As of Jun. 30, 2026)


XMAD:CBAV Clinica Baviera SA XMAD:CBAV
100 GF Score
Price €55.20
GF Value €41.30
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Clinica Baviera Moat Score?

Clinica Baviera has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Clinica Baviera has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Clinica Baviera might have No Moat - No discernible moat.

Clinica Baviera  (XMAD:CBAV) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Clinica Baviera Moat Score Related Terms

XMAD:CBAV
100GF Score
Clinica Baviera SA XMAD:CBAV
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €55.20 is trading 33.7% above its estimated GF Value™ of €41.30. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for XMAD:CBAV:

  • Moat Score: 0
  • GF Value™: €41.30 vs. price of €55.20 (33.7% above fair value)
  • GF Score™: 100/100 with 4 warning signs

No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clinica Baviera Business Description

Other Exchanges 0GWJ:UKD9Z:Germany
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
100GF Score

Get the complete analysis for XMAD:CBAV

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.20
Price
€41.30
GF Value